LT2931720T - Kieta dispersija, turinti geresnį tirpumą, apimanti tetrazolo darinį kaip aktyvų ingredientą - Google Patents

Kieta dispersija, turinti geresnį tirpumą, apimanti tetrazolo darinį kaip aktyvų ingredientą

Info

Publication number
LT2931720T
LT2931720T LTEP13863463.9T LT13863463T LT2931720T LT 2931720 T LT2931720 T LT 2931720T LT 13863463 T LT13863463 T LT 13863463T LT 2931720 T LT2931720 T LT 2931720T
Authority
LT
Lithuania
Prior art keywords
active ingredient
solid dispersion
improved solubility
tetrazole derivative
tetrazole
Prior art date
Application number
LTEP13863463.9T
Other languages
English (en)
Inventor
Yong Il Kim
Jun Young Choi
Young Keun Choi
Jae Hyun Park
Jong Soo Woo
Original Assignee
Hanmi Pharm. Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Pharm. Co., Ltd. filed Critical Hanmi Pharm. Co., Ltd.
Publication of LT2931720T publication Critical patent/LT2931720T/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/475Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
LTEP13863463.9T 2012-12-13 2013-12-12 Kieta dispersija, turinti geresnį tirpumą, apimanti tetrazolo darinį kaip aktyvų ingredientą LT2931720T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020120145603A KR101986683B1 (ko) 2012-12-13 2012-12-13 테트라졸 유도체를 활성 성분으로 포함하는 용해도가 개선된 고체 분산체
PCT/KR2013/011545 WO2014092489A1 (en) 2012-12-13 2013-12-12 Solid dispersion with improved solubility comprising tetrazole derivative as an active ingredient

Publications (1)

Publication Number Publication Date
LT2931720T true LT2931720T (lt) 2019-07-10

Family

ID=50934681

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP13863463.9T LT2931720T (lt) 2012-12-13 2013-12-12 Kieta dispersija, turinti geresnį tirpumą, apimanti tetrazolo darinį kaip aktyvų ingredientą

Country Status (38)

Country Link
US (1) US9283218B2 (lt)
EP (1) EP2931720B1 (lt)
JP (1) JP6355645B2 (lt)
KR (1) KR101986683B1 (lt)
CN (1) CN104870443B (lt)
AR (2) AR093706A1 (lt)
AU (1) AU2013360544B2 (lt)
BR (1) BR112015013905A2 (lt)
CA (1) CA2892376C (lt)
CL (1) CL2015001551A1 (lt)
CR (1) CR20150361A (lt)
DK (1) DK2931720T3 (lt)
DO (1) DOP2015000128A (lt)
EC (1) ECSP15029808A (lt)
ES (1) ES2731806T3 (lt)
GT (1) GT201500123A (lt)
HK (1) HK1212330A1 (lt)
HU (1) HUE044659T2 (lt)
IL (1) IL239327A (lt)
JO (1) JO3534B1 (lt)
LT (1) LT2931720T (lt)
MX (1) MX363644B (lt)
MY (1) MY174746A (lt)
NI (1) NI201500073A (lt)
NZ (1) NZ709071A (lt)
PE (1) PE20151066A1 (lt)
PH (1) PH12015501312A1 (lt)
PL (1) PL2931720T3 (lt)
PT (1) PT2931720T (lt)
RU (1) RU2662819C2 (lt)
SA (1) SA515360535B1 (lt)
SG (1) SG11201504067SA (lt)
SI (1) SI2931720T1 (lt)
TR (1) TR201908746T4 (lt)
TW (1) TWI652073B (lt)
UY (1) UY35186A (lt)
WO (1) WO2014092489A1 (lt)
ZA (1) ZA201503795B (lt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102044223B1 (ko) * 2016-09-12 2019-11-13 성균관대학교산학협력단 텔미사르탄을 포함하는 고체 분산체 및 이의 제조방법
CN111867562B (zh) * 2018-03-07 2023-07-07 陈献 不溶性药物的水性制剂
CZ2018188A3 (cs) * 2018-04-18 2019-10-30 Zentiva, K.S. Částice s obsahem amorfního empagliflozinu, způsob jejich přípravy a farmaceutický přípravek
EP3893867A1 (en) 2018-12-14 2021-10-20 Athenex HK Innovative Limited Therapeutic combinations of orally administered docetaxel and a p-gp inhibitor for the treatment of cancer
WO2020124070A1 (en) * 2018-12-14 2020-06-18 Athenex HK Innovative Limited Therapeutic combinations of orally administered irinotecan and a p-gp inhibitor for the treatment of cancer
WO2020168144A1 (en) 2019-02-14 2020-08-20 Teva Pharmaceuticals International Gmbh Solid state forms of n-[2-(2-{4-[2-(6,7-dimethoxy-3,4-dihydro-2(lh)- isoquinolinyl)ethyl] phenyl }-2h-tetrazol-5-yl)-4,5-dimethoxyphenyl] -4- oxo-4h-chromene-2-carboxamide and of its mesylate salt
WO2022011221A1 (en) 2020-07-10 2022-01-13 Teva Czech Industries S.R.O Solid state forms of n-[2-(2-{4-[2-(6,7-dimethoxy-3,4-dihydro-2(1h)-isoquinolinyl)ethyl]phenyl}-2h-tetrazol-5-yl)-4,5-dimethoxyphenyl]-4-oxo-4h-chromene-2-carboxamide mesylate salt
TW202233593A (zh) 2020-10-07 2022-09-01 美商亞瑟尼克斯公司 乙醯胺基-苯基四唑衍生物及其使用方法
JP2023548384A (ja) 2020-10-30 2023-11-16 アテネックス アールアンドディ エルエルシー Hm30181メシル酸塩の多形

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW487582B (en) * 1995-08-11 2002-05-21 Nissan Chemical Ind Ltd Method for converting sparingly water-soluble medical substance to amorphous state
JP2000309588A (ja) * 1999-04-28 2000-11-07 Taisho Pharmaceut Co Ltd 固体分散体
RU2006102981A (ru) * 2003-08-04 2007-09-20 Пфайзер Продактс Инк. (Us) Лекарственные формы, обеспечивающие контролируемое высвобождение ингибиторов белка-переносчика эфиров холестерина и немедленное высвобождение ингибиторов hmg-соа-редуктазы
CL2004001884A1 (es) 2003-08-04 2005-06-03 Pfizer Prod Inc Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
KR100557093B1 (ko) * 2003-10-07 2006-03-03 한미약품 주식회사 다약제 내성 저해 활성을 갖는 테트라졸 유도체 및 그의제조방법
KR100572411B1 (ko) 2003-10-23 2006-04-18 한미약품 주식회사 열역학적으로 안정한 무정형 토라세미드 고체분산체와이를 포함하는 약학 조성물 및 이의 제조 방법
MX2007004973A (es) 2004-10-25 2007-06-14 Japan Tobacco Inc Formulacion solida con solubilidad y estabilidad mejoradas y metodo para producir la formulacion.
KR100678824B1 (ko) * 2005-02-04 2007-02-05 한미약품 주식회사 용해성이 증가된 무정형 타크로리무스 고체분산체 및 이를포함하는 약제학적 조성물
SI1926476T1 (sl) * 2005-08-29 2013-07-31 Sanofi-Aventis U.S. Llc Amorfne trdne disperzije 7-kloro-N,N,5-trimetil-4-okso-3-fenil-3,5- dihidro-4H-piridazino/4,5-b/indol-1-acetamida
KR101466245B1 (ko) * 2010-01-15 2014-12-01 한미사이언스 주식회사 테트라졸 메탄설폰산 염의 제조방법 및 이에 사용되는 신규 화합물
KR20110132116A (ko) * 2010-06-01 2011-12-07 (주)국전약품 라록시펜 염산염을 포함하는 고체분산체, 이의 제조방법, 및 이를 포함하는 경구용 제제
US8557995B2 (en) * 2010-06-09 2013-10-15 Abbvie Inc. Solid dispersions containing kinase inhibitors

Also Published As

Publication number Publication date
KR20140076979A (ko) 2014-06-23
UY35186A (es) 2014-07-31
PH12015501312B1 (en) 2015-08-24
AR123783A2 (es) 2023-01-11
WO2014092489A1 (en) 2014-06-19
NI201500073A (es) 2016-01-06
AU2013360544B2 (en) 2017-05-11
SI2931720T1 (sl) 2019-08-30
RU2662819C2 (ru) 2018-07-31
TWI652073B (zh) 2019-03-01
CN104870443B (zh) 2018-09-14
CA2892376A1 (en) 2014-06-19
NZ709071A (en) 2019-08-30
US20150272943A1 (en) 2015-10-01
ES2731806T3 (es) 2019-11-19
EP2931720A1 (en) 2015-10-21
ECSP15029808A (es) 2016-01-29
HUE044659T2 (hu) 2019-11-28
PE20151066A1 (es) 2015-08-11
GT201500123A (es) 2018-10-08
HK1212330A1 (en) 2016-06-10
EP2931720A4 (en) 2016-06-29
CR20150361A (es) 2015-08-21
ZA201503795B (en) 2016-08-31
MX363644B (es) 2019-03-29
IL239327A0 (en) 2015-07-30
IL239327A (en) 2017-11-30
EP2931720B1 (en) 2019-04-24
US9283218B2 (en) 2016-03-15
SG11201504067SA (en) 2015-06-29
TW201429507A (zh) 2014-08-01
CA2892376C (en) 2020-10-27
MY174746A (en) 2020-05-13
PT2931720T (pt) 2019-06-25
SA515360535B1 (ar) 2017-07-17
KR101986683B1 (ko) 2019-06-10
DOP2015000128A (es) 2015-09-30
PH12015501312A1 (en) 2015-08-24
AU2013360544A1 (en) 2015-07-09
CN104870443A (zh) 2015-08-26
JP6355645B2 (ja) 2018-07-11
BR112015013905A2 (pt) 2017-07-11
DK2931720T3 (da) 2019-07-08
JP2016507489A (ja) 2016-03-10
CL2015001551A1 (es) 2015-09-25
MX2015006416A (es) 2015-08-14
AR093706A1 (es) 2015-06-17
PL2931720T3 (pl) 2019-09-30
JO3534B1 (ar) 2020-07-05
RU2015128002A (ru) 2017-01-16
TR201908746T4 (tr) 2019-07-22

Similar Documents

Publication Publication Date Title
HK1212330A1 (en) Solid dispersion with improved solubility comprising tetrazole derivative as an active ingredient
TWI561171B (en) Active compound combinations
HUE043469T2 (hu) Hatóanyagként uracil-vegyületet tartalmazó herbicid kompozíció
HUE039664T2 (hu) N-Arilamidinnel szubsztituált trifluoretil-szulfid-származékok mint atka- és rovarirtószerek
IL238328A0 (en) Stable preparations that include peracetic acid
ZA201308371B (en) Sustained release pheromone formulation
ZA201504520B (en) Active ingredient microparticles
ZA201306000B (en) Stable formulation
HK1205679A1 (en) Nicotine formulation
PT2908835T (pt) Formulações estáveis
ZA201306643B (en) Formulation comprising phenylaminopyrimidine derivatives as active agent
GB201320585D0 (en) Insecticidal compounds based on arylthiosulfonamide derivatives
HK1180461A1 (en) Chopping amplifier
GB201210530D0 (en) Extended release formulations
EP2920475A4 (en) ACTIVE BOLT RELEASE SYSTEM
IL234771A0 (en) Nicotine formulation
PT2934506T (pt) Derivados de glutamato para utilização tópica como princípio ativo imunomodulador
AU2012903717A0 (en) Stabilizing drawbar mounting device
AU2012904552A0 (en) An Improved Towball